Repository logo
 

Tūtakarerewa-Indigenous Advocacy and Structural Racism in Bowel Cancer Screening in Aotearoa New Zealand

aut.relation.endpage89
aut.relation.issue1627
aut.relation.journalNew Zealand Medical Journal
aut.relation.startpage79
aut.relation.volume138
dc.contributor.authorScott, N
dc.contributor.authorKidd, Jacquie
dc.contributor.authorArnet, H
dc.contributor.authorDargaville, C
dc.contributor.authorGoza, M
dc.contributor.authorCrengle, S
dc.contributor.authorJones, R
dc.contributor.authorKerrison, C
dc.contributor.authorMcKree Jansen, R
dc.date.accessioned2026-01-07T01:59:57Z
dc.date.available2026-01-07T01:59:57Z
dc.date.issued2025-12-12
dc.description.abstractAotearoa New Zealand has one of the highest bowel cancer rates in the world. Bowel cancer incidence is increasing for Māori (the Indigenous people of Aotearoa), while trending downwards for non-Māori. Over half of Māori who get bowel cancer are diagnosed before the age of 60 years and are more likely than non-Māori to die within 2 years. Pacific people also experience bowel cancer inequities. In 2016, a national bowel screening programme for Aotearoa was announced, with an age range of 60-74 years. However, equity modelling showed that the proposed programme would disproportionately benefit non-Māori and that lowering the screening age for Māori and Pacific peoples to 50 years could achieve equal health gains. Over subsequent years, Māori cancer leaders advocated for policy change to lower the bowel screening age by 10 years for Māori. They used academic publications, presentations, letters, position statements, media stories and meetings with government leaders. Despite this advocacy, in 2020, the Government announced it was not going to lower the bowel screening age for Māori and Pacific peoples. The advocates persevered. They were supported in their efforts by new data that further confirmed the increasing bowel cancer incidence for Māori. In 2022, the Government committed to lowering the bowel cancer screening age to 50 for Māori and Pacific peoples. However, what followed was a tardy, phased rollout in only three regions. A year on, a new government embarked on a politically motivated agenda to reject ethnically targeted policies, with further significant equity changes to the programme announced. This paper summarises the lobbying efforts of cancer leaders and the government response, revealing structural and institutional racism, represented by inaction and active rejection of evidence-based advice. We describe the perseverance required to advocate for equity in the face of structural racism and the cost to Māori lives while inaction and racism persist.
dc.identifier.citationNew Zealand Medical Journal, ISSN: 0028-8446 (Print); 1175-8716 (Online), Pasifika Medical Association Group, 138(1627), 79-89. doi: 10.26635/6965.7186
dc.identifier.doi10.26635/6965.7186
dc.identifier.issn0028-8446
dc.identifier.issn1175-8716
dc.identifier.urihttp://hdl.handle.net/10292/20450
dc.languageeng
dc.publisherPasifika Medical Association Group
dc.relation.urihttps://nzmj.org.nz/media/pages/journal/vol-138-no-1627/tutakarerewa-indigenous-advocacy-and-structural-racism-in-bowel-cancer-screening-in-aotearoa-new-zealand/edc7637fd2-1765233974/7186.pdf
dc.rightsOpen Access. The New Zealand Medical Journal is fully available to individual subscribers and does not incur a subscription fee. This applies to both New Zealand and international subscribers.
dc.rights.accessrightsOpenAccess
dc.subject4206 Public Health
dc.subject42 Health Sciences
dc.subjectHealth Services
dc.subjectClinical Research
dc.subjectCancer
dc.subjectHealth Disparities
dc.subjectWomen's Health
dc.subjectMinority Health
dc.subjectCancer
dc.subject11 Medical and Health Sciences
dc.subjectGeneral & Internal Medicine
dc.subject32 Biomedical and clinical sciences
dc.subject42 Health sciences
dc.subject.meshHumans
dc.subject.meshNew Zealand
dc.subject.meshEarly Detection of Cancer
dc.subject.meshMiddle Aged
dc.subject.meshAged
dc.subject.meshColorectal Neoplasms
dc.subject.meshRacism
dc.subject.meshMale
dc.subject.meshHealthcare Disparities
dc.subject.meshMass Screening
dc.subject.meshIncidence
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshColorectal Neoplasms
dc.subject.meshMass Screening
dc.subject.meshIncidence
dc.subject.meshAged
dc.subject.meshMiddle Aged
dc.subject.meshNew Zealand
dc.subject.meshFemale
dc.subject.meshMale
dc.subject.meshHealthcare Disparities
dc.subject.meshEarly Detection of Cancer
dc.subject.meshRacism
dc.subject.meshHumans
dc.subject.meshNew Zealand
dc.subject.meshEarly Detection of Cancer
dc.subject.meshMiddle Aged
dc.subject.meshAged
dc.subject.meshColorectal Neoplasms
dc.subject.meshRacism
dc.subject.meshMale
dc.subject.meshHealthcare Disparities
dc.subject.meshMass Screening
dc.subject.meshIncidence
dc.subject.meshFemale
dc.titleTūtakarerewa-Indigenous Advocacy and Structural Racism in Bowel Cancer Screening in Aotearoa New Zealand
dc.typeJournal Article
pubs.elements-id749150

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Scott et al._2025_Tūtakarerewa-Indigenous advocacy and structural racism in bowel cancer screening in Aotearoa New Zealand.pdf
Size:
377.83 KB
Format:
Adobe Portable Document Format
Description:
Journal article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.37 KB
Format:
Plain Text
Description: